Ari Bousbib - IQVIA Holdings Insider

Q -- USA Stock  

USD 103.48  0.57  0.55%


Mr. Ari Bousbib is a Chairman of the Board, President, Chief Executive Officer of the Company. He assumed this position in October 2016 following the Merger of Quintiles and IMS Health. From 2010 until the Merger, Mr. Bousbib served as chairman and CEO of IMS Health. In 2014, he led the successful IPO of the company. Prior to joining IMS Health, Mr. Bousbib spent 14 years at United Technologies Corporationrationration, an aerospace, defense and building industries company. From 2008 until 2010, he served as President of UTCs Commercial Companies, including Otis Elevator Company, Carrier Corporationrationration, UTC Fire Security and UTC Power Inc. From 2002 until 2008, Mr. Bousbib was President of Otis, and from 2000 to 2002 he served as its Chief Operating Officer. Previously, Mr. Bousbib was a partner at Booz Allen Hamilton. Mr. Bousbib currently serves on the board of directors of The Home Depot, Inc. and is a member of the Harvard Medical School Health Care Policy Advisory Council. He previously served on the board of directors of Best Buy, Inc. and was appointed by the President of the United States to serve on the Presidents Commission on White House Fellowships
Age: 55  Director Since 2016  MBA    
Bousbib holds a MS Degree in Mathematics and Mechanical Engineering from the Ecole Superieure des Travaux Publics, Paris, and an M.B.A. from Columbia University.

Ari Bousbib Latest Insider Activity

Management Efficiency

The company has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.
The company has accumulated 9.77 B in total debt with debt to equity ratio (D/E) of 130.0 implying that the company may be unable to produce cash to meet its debt commitments. IQVIA Holdings has Current Ratio of 1.2 implying that it may have difficulties to pay its interest payments when they become due.

Similar Executives

Showing few of many executives


Carol DavidsonAllergan plc
James FarrellAbbott Laboratories
Raul AlvarezEli Lilly and Company
Carlos RepresasMerck Co
Shane CookeEndo International plc
Juan LucianoEli Lilly and Company
David AltshulerVertex Pharmaceuticals Incorpor
Michael GallagherAllergan plc
Daniel StarksAbbott Laboratories
Thomas GlocerMerck Co
Christopher CoughlinAllergan plc
Catherine KlemaAllergan plc
Sharad MansukaniEndo International plc
Alice SchwartzBio Rad Laboratories
Michael HyattEndo International plc
Kneeland YoungbloodMallinckrodt Public Limited Com
Inge ThulinMerck Co
Gregory HinckleyBio Rad Laboratories
David GreenwayVertex Pharmaceuticals Incorpor
Deborah NeffBio Rad Laboratories
Jill SmithEndo International plc

Entity Summary

Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. IQVIA Holdings (Q) is traded on New York Stock Exchange in USA. It is located in 4820 Emperor Blvd., Durham, NC 27703, United States and employs 36,100 people.

IQVIA Holdings Leadership Team

Thomas Pike, CEO
Ari Bousbib, Director, MBA
Michael Evanisko, Director
Leonard Schaeffer, Director
James Erlinger, President, MBA
John Danhakl, Director, MBA
Richard Staub, President
Michael McDonnell, President
Kevin Gordon, COO
John Leonard, Director, Ph.D
James Fasano, Director, MBA
Jonathan Coslet, Director, MBA
John Connaughton, Director, MBA
Haiyuan Lo, Director
Ronald Rittenmeyer, Director, MBA
Dennis Gillings, Chairman, Ph.D
Todd Sisitsky, Director, MBA
Jack Greenberg, Director, CPA
Kevin Knightly, President

Stock Performance Indicators

Did you try this?

Run Portfolio File Import Now

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Portfolio File Import

Trending Equities

Currently Active Assets on Macroaxis
Purchased over 100 shares of
few days ago
Traded for 10.44
Purchased over 300 shares of
few days ago
Traded for 6.24
Purchased over 70 shares of
few days ago
Traded for 23.42
Purchased over 200 shares of
few days ago
Traded for 8.1
Purchased over 400 shares of
few days ago
Traded for 4.74
Additionally take a look at Your Equity Center. Please also try Coins and Tokens Correlation module to utilize digital token correlation table to build portfolio of cryptocurrencies across multiple exchanges.